Classifications

• • C—CHEMISTRY; METALLURGY
  • C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
  • C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
  • C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
  • C11D3/16—Organic compounds
  • C11D3/38—Products with no well-defined composition, e.g. natural products
  • C11D3/386—Preparations containing enzymes, e.g. protease or amylase
  • C11D3/38681—Chemically modified or immobilised enzymes
• • C—CHEMISTRY; METALLURGY
  • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
  • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
  • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
  • C12N9/14—Hydrolases (3)
  • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
  • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
  • C12N9/52—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from bacteria or Archaea
  • C12N9/54—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from bacteria or Archaea bacteria being Bacillus
• • A—HUMAN NECESSITIES
  • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
  • A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
  • A23G4/00—Chewing gum
  • A23G4/06—Chewing gum characterised by the composition containing organic or inorganic compounds
  • A23G4/12—Chewing gum characterised by the composition containing organic or inorganic compounds containing microorganisms or enzymes; containing paramedical or dietetical agents, e.g. vitamins
  • A23G4/123—Chewing gum characterised by the composition containing organic or inorganic compounds containing microorganisms or enzymes; containing paramedical or dietetical agents, e.g. vitamins containing microorganisms, enzymes
• • A—HUMAN NECESSITIES
  • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
  • A23K—FODDER
  • A23K20/00—Accessory food factors for animal feeding-stuffs
  • A23K20/10—Organic substances
  • A23K20/189—Enzymes
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K8/00—Cosmetics or similar toiletry preparations
  • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
  • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
  • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
  • A61K8/66—Enzymes
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
  • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
  • A61Q19/00—Preparations for care of the skin
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
  • A61Q19/00—Preparations for care of the skin
  • A61Q19/10—Washing or bathing preparations
• • C—CHEMISTRY; METALLURGY
  • C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
  • C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
  • C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
  • C11D3/16—Organic compounds
  • C11D3/38—Products with no well-defined composition, e.g. natural products
  • C11D3/386—Preparations containing enzymes, e.g. protease or amylase
• • C—CHEMISTRY; METALLURGY
  • C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
  • C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
  • C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
  • C11D3/16—Organic compounds
  • C11D3/38—Products with no well-defined composition, e.g. natural products
  • C11D3/386—Preparations containing enzymes, e.g. protease or amylase
  • C11D3/38609—Protease or amylase in solid compositions only
• • C—CHEMISTRY; METALLURGY
  • C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
  • C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
  • C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
  • C11D3/16—Organic compounds
  • C11D3/38—Products with no well-defined composition, e.g. natural products
  • C11D3/386—Preparations containing enzymes, e.g. protease or amylase
  • C11D3/38618—Protease or amylase in liquid compositions only
• • C—CHEMISTRY; METALLURGY
  • C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
  • C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
  • C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
  • C11D3/39—Organic or inorganic per-compounds
  • C11D3/3902—Organic or inorganic per-compounds combined with specific additives
  • C11D3/3905—Bleach activators or bleach catalysts
  • C11D3/3907—Organic compounds
• • C—CHEMISTRY; METALLURGY
  • C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
  • C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
  • C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
  • C11D3/39—Organic or inorganic per-compounds
  • C11D3/3945—Organic per-compounds
• • C—CHEMISTRY; METALLURGY
  • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
  • C12Y—ENZYMES
  • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
• • C—CHEMISTRY; METALLURGY
  • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
  • C12Y—ENZYMES
  • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
  • C12Y304/21—Serine endopeptidases (3.4.21)
  • C12Y304/21062—Subtilisin (3.4.21.62)
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
  • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
  • A61K2800/86—Products or compounds obtained by genetic engineering
• • C—CHEMISTRY; METALLURGY
  • C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
  • C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
  • C11D2111/00—Cleaning compositions characterised by the objects to be cleaned; Cleaning compositions characterised by non-standard cleaning or washing processes
  • C11D2111/10—Objects to be cleaned
  • C11D2111/12—Soft surfaces, e.g. textile
• • C—CHEMISTRY; METALLURGY
  • C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
  • C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
  • C11D2111/00—Cleaning compositions characterised by the objects to be cleaned; Cleaning compositions characterised by non-standard cleaning or washing processes
  • C11D2111/10—Objects to be cleaned
  • C11D2111/14—Hard surfaces

Definitions

• Senne proteases are a subgrouo of carbonyl hydrolases They comprise a diverse class of enzymes having a wide range of specificities and biological functions Stroud R Sci Amer 131 74-88 Despite their functional diversity, the catalytic machinery of senne proteases has been approached by at least two genetically distinct families of enzymes 1 ) the subtilisins and 2) the mammalian chymotrypsin-related and homologous bacterial senne proteases (e g , trypsin and S.
• subtilisins are senne proteases (approx MW 27,500) which are secreted in large amounts from a wide variety of Bacillus species and other microorganisms
• the protein sequence of subtilisin has been determined from at least nine different species of Bacillus Markland, F S , et al (1983), Hoppe-Seyler's Z Physiol Chem 364 1537-1540
• the three-dimensional crystallographic structure of subtilisins from Bacillus amyloliquefaciens, Bacillus licheniforimis and several natural variants of B lentus have been reported These studies indicate that although subtilisin is genetically unrelated to the mammalian senne proteases, it has a similar active site structure
• the x-ray crystal structures of subtilisin containing covalently bound peptide inhibitors Robottus, J D , et al (1972), Biochemistry, 11-2439-2449
• product complexes Robottus, J D , et al (1976
• the preferred protease variant enzymes of the present invention comprise the substitution of ammo acid residues in the following combinations All of the residue positions correspond to positions of Bacillus amyloliquefaciens subtilisin
• protease variant including substitutions of the am o acid residues at position 62 and at one or more of the following positions 103, 104, 109, 159, 213, 232, 236, 245, 248 and 252,
• protease variant including substitutions of the ammo acid residues at position 212 and at one or more of the following positions 12, 98 102 103 104, 159 232, 236, 245, 248 and 252,
• a protease variant including substitutions of the am o acid residues at position 232 and at one or more of the following positions 1 , 9, 12, 61 , 62, 68, 76, 97, 98, 101 , 102, 103, 104, 109, 130, 131 , 159, 183, 185, 205, 209, 210, 212, 213, 217, 230, 236, 245, 248, 252, 257, 260 270 and 275, (5) a protease variant including substitutions of the ammo acid residues at position 232 and at one or more of the following positions 103, 104, 236 and 245, (6) a protease variant including substitutions of the ammo acid residues at position 232 and 103 and at one or more of the following positions 1 , 9, 12, 61 , 62, 68, 76, 97, 98, 101 , 102, 103, 104, 109, 130, 131 , 159,
• a protease variant including substitutions of the amino acid residues at position 232 ana 104 and at one or more of the following positions 1 , 9. 12, 61 , 62, 68, 76, 97, 98. 101 , 102, 103, 104, 109. 130, 131 , 159, 183. 185, 205, 209, 210, 212, 213, 217, 230, 236, 245. 248, 252, 257. 260, 270 and 275;
• a protease variant including substitutions of the am o acid residues at position 232 and 236 and at one or more of the following positions 1 , 9, 12, 61 , 62, 68, 76, 97, 98, 101 , 102. 103, 104. 109, 130, 131 , 159. 183, 185, 205, 209, 210, 212, 213, 217, 230, 236, 245, 248, 252. 257, 260, 270 and 275;
• a protease variant including substitutions of the ammo acid residues at position 232 and 245 and at one or more of the following positions 1 , 9, 12, 61 , 62, 68, 76, 97, 98, 101 , 102. 103, 104, 109, 130, 131 , 159, 183, 185, 205, 209, 210, 212, 213, 217, 230, 236, 245, 248. 252, 257, 260.
• a protease variant inclu ⁇ ing substitutions of the amino acid residues at position 232, 103, 104, 236 and 245 and at one or more of the following positions 1 , 9, 12, 61 , 62, 68, 76, 97, 98, 101 , 102, 103, 104, 109, 130, 131 , 159, 183, 185, 205, 209, 210, 212, 213, 217, 230, 236, 245, 248, 252, 257, 260, 270 and 275;
• a protease variant including substitutions of the ammo acid residues at position 252 and at one or more of the following positions 1 , 9, 12, 61 , 62, 68, 97, 98,
• a protease variant including substitutions of the ammo acid residues at position 252 and at one or more of the following positions 103, 104. 236 and 245;
• a protease variant including substitutions of the ammo acid residues at positions 252 and 103 and at one or more of the following positions 1 , 9, 12, 61 , 62, 68, 97, 98, 101 , 102, 103, 104, 109, 130, 131 , 159, 183, 185, 210, 212, 213, 217, 232, 236, 245, 248 and 270;
• a protease variant including substitutions of the am o acid residues at positions 252 and 104 and at one or more of the following positions 1 , 9, 12, 61 , 62,
• a protease variant including substitutions of the amino acid residues at positions 252 and 236 and at one or more of the following positions 1 , 9, 12. 61 , 62. 68, 97, 98, 101 , 102, 103, 104. 109, 130, 131 , 159, 183, 185, 210, 212, 213, 217, 232. 236, 245, 248 and 270;
• a protease variant including substitutions of the amino acid residues at positions 252 and 245 and at one or more of the following positions 1 , 9, 12. 61 , 62, 68, 97, 98, 101 , 102, 103, 104. 109, 130. 131. 159, 183, 185, 210. 212, 213, 217. 232, 236, 245. 248 and 270;
• a protease variant including substitutions of the amino acid residues at positions 252, 103, 104, 236 and 245 and at one or more of the following positions 1, 9. 12, 61 , 62, 68. 97. 98, 101 , 102, 103, 104, 109. 130, 131 , 159, 183, 185, 210, 212, 213, 217, 232, 236, 245, 248 and 270; and
• a protease variant including substitutions of the amino acid residues at position 257 and at one or more of the following positions 68, 103, 104. 205. 209, 210, 232, 236. 245 and 275.
• More preferred protease variants are substitution sets selected from the group consisting of residue positions corresponding to positions in Table 1 of Bacillus amyloliquefaciens subtilisin:
• protease variants are substitution sets selected from the group consisting of residue positions corresponding to positions in Table 2 of Bacillus amyloliquefaciens subtilisin:
• Another object of the invention is to provide host cells transformed with such vectors, as well as host cells which are capable of expressing such DNA to produce protease variants either intracellularly or extracellularly.
• an animal feed comprising a protease variant of the present invention.
• a composition for the treatment of a textile comprising a protease variant of the present invention.
• Figs. 1 A-C depict the DNA and am o acid sequence for Bacillus amyloliquefaciens subtilisin and a partial restriction map of this gene.
• Fig. 2 depicts the conserved amino acid residues among subtilisins from Bacillus amyloliquefaciens (BPN)' and Bacillus lentus (wild-type).
• Figs. 3A and 3B depict the amino acid sequence of four subtilisins.
• the top line represents the amino acid sequence of subtilisin from Bacillus amyloliquefaciens subtilisin (also sometimes referred to as subtilisin BPN').
• the second line depicts the ammo acid sequence of subtilisin from Bacillus subtilis
• the third line depicts the am o acid sequence of subtilisin from B. licheniformis.
• the fourth line depicts the ammo acid sequence of subtilisin from Bacillus lentus (also referred to as subtilisin 309 in PCT WO89/06276).
• the symbol * denotes the absence of specific amino acid residues as compared to subtilisin BPN'.
• Proteases are carbonyl hydrolases which generally act to cleave peptide bonds of proteins or peptides.
• protease means a naturally- occurring protease or a recombinant protease.
• Naturally-occurring proteases include ⁇ -aminoacylpeptide hydrolase, peptidylamino acid hydrolase, acylamino hydrolase, serine carboxypeptidase, metallocarboxypeptidase, thiol proteinase, carboxylproteinase and metalloproteinase. Serine, metallo, thiol and acid proteases are included, as well as endo and exo-proteases.
• the present invention includes protease enzymes which are non-naturally occurring carbonyl hydrolase variants (protease variants) having a different proteolytic activity, stability, substrate specificity, pH profile and/or performance characteristic as compared to the precursor carbonyl hydrolase from which the amino acid sequence of the variant is derived.
• protease variants have an amino acid sequence not found in nature, which is derived by substitution of a plurality of amino acid residues of a precursor protease with different amino acids.
• the precursor protease may be a naturally-occurring protease or a recombinant protease.
• protease variants useful herein encompass the substitution of any of the nineteen naturally occurring L-amino acids at the designated ammo acid residue positions. Such substitutions can be made in any precursor subtilisin (procaryotic, eucaryotic, mammalian, etc.). Throughout this application reference is made to various amino acids by way of common one - and three-letter codes. Such codes are identified in Dale, M.W. (1989), Molecular Genetics of Bacteria, John Wiley & Sons, Ltd., Appendix B.
• protease variants useful herein are preferably derived from a Bacillus subtilisin. More preferably, the protease variants are derived from Bacillus lentus subtilisin and/or subtilisin 309.
• Subtilisins are bacterial or fungal proteases which generally act to cleave peptide bonds of proteins or peptides.
• subtilisin means a naturally- occurring subtilisin or a recombinant subtilisin. A series of naturally-occurring subtilisins is known to be produced and often secreted by various microbiai species. Amino acid sequences of the members of this series are not entirely homologous.
• subtilisins in this series exhibit the same or similar type of proteolytic activity.
• This class of serine proteases shares a common amino acid sequence defining a catalytic triad which distinguishes them from the chymotrypsin related class of serine proteases.
• the subtilisins and chymotrypsin related serine proteases both have a catalytic triad comprising aspartate, histidine and serine.
• the relative order of these amino acids reading from the amino to carboxy terminus, is aspartate-histidine-serine.
• the relative order is histidine-aspartate-serine.
• subtilisin herein refers to a serine protease having the catalytic triad of subtilisin related proteases. Examples include but are not limited to the subtilisins identified in Fig. 3 herein. Generally and for purposes of the present invention, numbering of the amino acids in proteases corresponds to the numbers assigned to the mature Bacillus amyloliquefaciens subtilisin sequence presented in Fig. 1.
• Recombinant subtilisin or “recombinant protease” refer to a subtilisin or protease in which the DNA sequence encoding the subtilisin or protease is modified to produce a variant (or mutant) DNA sequence which encodes the substitution, deletion or insertion of one or more ammo acids in the naturally-occurring amino acid sequence. Suitable methods to produce such modification, and which may be combined with those disclosed herein, include those disclosed in US Patent RE
• Non-human subtilisins and the DNA encoding them may be obtained from many procaryotic and eucaryotic organisms. Suitable examples of procaryotic organisms include gram negative organisms such as E. coli or Pseudomonas and gram positive bacteria such as Micrococcus or Bacillus. Examples of eucaryotic organisms from which subtilisin and their genes may be obtained include yeast such as Saccharomyces cerevisiae, fungi such as Aspergillus sp.
• a “protease variant” has an amino acid sequence which is derived from the amino acid sequence of a "precursor protease".
• the precursor proteases include naturally-occurring proteases and recombinant proteases.
• the amino acid sequence of the protease variant is "derived” from the precursor protease amino acid sequence by the substitution, deletion or insertion of one or more amino acids of the precursor amino acid sequence. Such modification is of the "precursor DNA sequence” which encodes the amino acid sequence of the precursor protease rather than manipulation of the precursor protease enzyme per se.
• Suitable methods for such manipulation of the precursor DNA sequence include methods disclosed herein, as well as methods known to those skilled in the art (see, for example, EP 0 328299, WO89/06279 and the US patents and applications already referenced herein).
• Specific substitutions of amino acids at one or more residue positions corresponding to residue positions selected from the group consisting of 62, 212, 230, 232, 252 and 257 of Bacillus amyloliquefaciens subtilisin are identified herein.
• Preferred variants are those having combinations of substitutions at residue positions corresponding to positions of Bacillus amyloliquefaciens subtilisin in Table 1
• More preferred variants are those having combinations of substitutions at residue positions corresponding to positions of Bacillus amyloliquefaciens subtilisin in Table 2.
• amino acid position numbers refer to those assigned to the mature Bacillus amyloliquefaciens subtilisin sequence presented in Fig. 1.
• the invention is not limited to the mutation of this particular subtilisin but extends to precursor proteases containing am o acid residues at positions which are "equivalent" to the particular identified residues in Bacillus amyloliquefaciens subtilisin.
• the precursor protease is Bacillus lentus subtilisin and the substitutions are made at the equivalent amino acid residue positions in B. lentus corresponding to those listed above.
• a residue (amino acid) position of a precursor protease is equivalent to a residue of Bacillus amyloliquefaciens subtilisin if it is either homologous (i.e., corresponding in position in either primary or tertiary structure) or analogous to a specific residue or portion of that residue in Bacillus amyloliquefaciens subtilisin (i.e., having the same or similar functional capacity to combine, react, or interact chemically).
• the amino acid sequence of a precursor protease is directly compared to the Bacillus amyloliquefaciens subtilisin primary sequence and particularly to a set of residues known to be invariant in subtilisins for which sequence is known.
• Fig. 2 herein shows the conserved residues as between B. amyloliquefaciens subtilisin and B. lentus subtilisin.
• the residues equivalent to particular amino acids in the primary sequence of Bacillus amyloliquefaciens subtilisin are defined.
• Alignment of conserved residues preferably should conserve 100% of such residues. However, alignment of greater than 75% or as little as 50% of conserved residues is also adequate to define equivalent residues.
• Conservation of the catalytic triad, Asp32/His64/Ser221 should be maintained.
• Siezen et al. (1991) Protein Eng. 4(7):719-737 shows the alignment of a large number of serine proteases. Siezen et al. refer to the grouping as subtilases or subtilisin-like serine proteases.
• subtilisin from Bacillus amyloliquefaciens, Bacillus subtilis, Bacillus licheniformis (carlsbergensis) and Bacillus lentus are aligned to provide the maximum amount of homology between amino acid sequences.
• a comparison of these sequences shows that there are a number of conserved residues contained in each sequence. These conserved residues (as between BPN' and B. lentus) are identified in Fig. 2.
• subtilisins subtilisin may be used to define the corresponding equivalent amino acid residues of Bacillus amyloliquefaciens subtilisin in other subtilisins such as subtilisin from Bacillus lenius (PCT Publication No. W089/06279 published July 13, 1989), the preferred protease precursor enzyme herein, or the subtilisin referred to as PB92 (EP 0 328 299), which is highly homologous to the preferred Bacillus lentus subtilisin.
• the amino acid sequences of certain of these subtilisins are aligned in Figs. 3A and 3B with the sequence of Bacillus amyloliquefaciens subtilisin to produce the maximum homology of conserved residues.
• Equivalent residues are defined as those for which the atomic coordinates of two or more of the main chain atoms of a particular amino acid residue of the precursor protease and Bacillus amyloliquefaciens subtilisin (N on N, CA on CA. C on C and O on O) are within 0.13nm and preferably 0.1 nm after alignment. Alignment is achieved after the best model has been oriented and positioned to give the maximum overlap of atomic coordinates of non- hydrogen protein atoms of the protease in question to the Bacillus amyloliquefaciens subtilisin. The best model is the crystallographic model giving the lowest R factor for experimental diffraction data at the highest resolution available.
• Equivalent residues which are functionally analogous to a specific residue of Bacillus amyloliquefaciens subtilisin are defined as those amino acids of the precursor protease which may adopt a conformation such that they either alter, modify or contribute to protein structure, substrate binding or catalysis in a manner defined and attributed to a specific residue of the Bacillus amyloliquefaciens subtilisin.
• residues of the precursor protease for which a tertiary structure has been obtained by x-ray crystallography
• the atomic coordinates of at least two of the side chain atoms of the residue lie with 0.13nm of the corresponding side chain atoms of Bacillus amyloliquefaciens subtilisin.
• the coordinates of the three dimensional structure of Bacillus amyloliquefaciens subtilisin are set forth in EPO Publication No. 0 251 446 (equivalent to US Patent 5,182,204. the disclosure of which is incorporated herein by reference) and can be used as outlined above to determine equivalent residues on the level of tertiary structure.
• protease variants of the present invention include the mature forms of protease variants, as well as the pro- and prepro-forms of such protease variants.
• the prepro-forms are the preferred construction since this facilitates the expression, secretion and maturation of the protease variants.
• Prosequence refers to a sequence of ammo acids bound to the N-terminal portion of the mature form of a protease which when removed results in the appearance of the "mature" form of the protease. Many proteolytic enzymes are found in nature as translational proenzyme products and, in the absence of post- translational processing, are expressed in this fashion.
• a preferred prosequence for producing protease variants is the putative prosequence of Bacillus amyloliquefaciens subtilisin, although other protease prosequences may be used.
• a “signal sequence” or “presequence” refers to any sequence of amino acids bound to the N-terminal portion of a protease or to the N-terminal portion of a proprotease which may participate in the secretion of the mature or pro forms of the protease.
• This definition of signal sequence is a functional one, meant to include all those amino acid sequences encoded by the N-terminal portion of the protease gene which participate in the effectuation of the secretion of protease under native conditions.
• the present invention utilizes such sequences to effect the secretion of the protease variants as defined herein.
• One possible signal sequence comprises the first seven amino acid residues of the signal sequence from Bacillus subtilis subtilisin fused to the remainder of the signal sequence of the subtilisin from Bacillus lentus.
• a “prepro” form of a protease variant consists of the mature form of the protease having a prosequence operably linked to the amino terminus of the protease and a "pre” or “signal” sequence operably linked to the amino terminus of the prosequence.
• “Expression vector” refers to a DNA construct containing a DNA sequence which is operably linked to a suitable control sequence capable of effecting the expression of said DNA in a suitable host.
• control sequences include a promoter to effect transcription, an optional operator sequence to control such transcription, a sequence encoding suitable mRNA ribosome binding sites and sequences which control termination of transcription and translation.
• the vector may be a plasmid, a phage particle, or simply a potential genomic insert. Once transformed into a suitable host, the vector may replicate and function independently of the host genome, or may, in some instances, integrate into the genome itself.
• plasmid and vector are sometimes used interchangeably as the plasmid is the most commonly used form of vector at present. However, the invention is intended to include such other forms of expression vectors which serve equivalent functions and which are, or become, known in the art.
• the "host cells” used in the present invention generally are procaryotic or eucaryotic hosts which preferably have been manipulated by the methods disclosed in US Patent RE 34,606 to render them incapable of secreting enzymatically active endoprotease.
• a preferred host cell for expressing protease is the Bacillus strain BG2036 which is deficient in enzymatically active neutral protease and alkaline protease (subtilisin). The construction of strain BG2036 is described in detail in US Patent 5,264,366.
• Bacillus subtilis 1168 also described in US Patent RE 34,606 and US Patent 5,264,366, the disclosure of which are incorporated herein by reference
• Bacillus strain such as B. licheniformis, B. lentus, etc.
• Host cells are transformed or transfected with vectors constructed using recombinant DNA techniques. Such transformed host cells are capable of either replicating vectors encoding the protease variants or expressing the desired protease variant. In the case of vectors which encode the pre- or prepro-form of the protease variant, such variants, when expressed, are typically secreted from the host cell into the host cell medium. "Operably linked, " when describing the relationship between two DNA regions, simply means that they are functionally related to each other. For example, a presequence is operably linked to a peptide if it functions as a signal sequence, participating in the secretion of the mature form of the protein most probably involving cleavage of the signal sequence. A promoter is operably linked to a coding sequence if it controls the transcription of the sequence; a ribosome binding site is operably linked to a coding sequence if it is positioned so as to permit translation.
• the genes encoding the naturally-occurring precursor protease may be obtained in accord with the general methods known to those skilled in the art.
• the methods generally comprise synthesizing labeled probes having putative sequences encoding regions of the protease of interest, preparing genomic libraries from organisms expressing the protease, and screening the libraries for the gene of interest by hybridization to the probes. Positively hybridizing clones are then mapped and sequenced.
• the cloned protease is then used to transform a host cell in order to express the protease.
• the protease gene is then iigated into a high copy number plasmid.
• This plasmid repiicates in hosts in the sense that it contains the well-known elements necessary for plasmid replication: a promoter operably linked to the gene in question (which may be supplied as the gene's own homologous promoter if it is recognized, i.e., transcribed, by the host), a transcription termination and poiyadenylation region (necessary for stability of the mRNA transcribed by the host from the protease gene in certain eucaryotic host cells) which is exogenous or is supplied by the endogenous terminator region of the protease gene and, desirably, a selection gene such as an antibiotic resistance gene that enables continuous cultural maintenance of plasmid-infected host cells by growth in antibiotic-containing media.
• High copy number piasmids also contain an origin of replication for the host, thereby enabling large numbers of piasmids to be generated in the cytoplasm without chromosomal limitations.
• the gene can be a natural B. lentus gene.
• a synthetic gene encoding a naturally-occurring or mutant precursor protease may be produced.
• the DNA and/or amino acid sequence of the precursor protease is determined.
• Multiple, overlapping synthetic single-stranded DNA fragments are thereafter synthesized, which upon hybridization and ligation produce a synthetic DNA encoding the precursor protease.
• An example of synthetic gene construction is set forth in Example 3 of US Patent 5,204,015, the disclosure of which is incorporated herein by reference.
• the following cassette mutagenesis method may be used to facilitate the construction of the protease variants of the present invention, although other methods may be used.
• the naturally-occurring gene encoding the protease is obtained and sequenced in whole or in part. Then the sequence is scanned for a point at which it is desired to make a mutation (deletion, insertion or substitution) of one or more amino acids in the encoded enzyme. The sequences flanking this point are evaluated for the presence of restriction sites for replacing a short segment of the gene with an oligonucleotide pool which when expressed will encode various mutants.
• restriction sites are preferably unique sites within the protease gene so as to facilitate the replacement of the gene segment.
• any convenient restriction site which is not overly redundant in the protease gene may be used, provided the gene fragments generated by restriction digestion can be reassembled in proper sequence, if restriction sites are not present at locations within a convenient distance from the selected point (from 10 to 15 nucleotides), such sites are generated by substituting nucleotides in the gene in such a fashion that neither the reading frame nor the amino acids encoded are changed in the final construction. Mutation of the gene in order to change its sequence to conform to the desired sequence is accomplished by M13 primer extension in accord with generally known methods.
• flanking region sequences The task of locating suitable flanking regions and evaluating the needed changes to arrive at two convenient restriction site sequences is made routine by the redundancy of the genetic code, a restriction enzyme map of the gene and the large number of different restriction enzymes. Note that if a convenient flanking restriction site is available, the above method need be used only in connection with the flanking region which does not contain a site.
• the restriction sites flanking the positions to be mutated are digested with the cognate restriction enzymes and a plurality of end termini-complementary oligonucleotide cassettes are ligated into the gene.
• the mutagenesis is simplified by this method because all of the oligonucleotides can be synthesized so as to have the same restriction sites, and no synthetic linkers are necessary to create the restriction sites.
• proteolytic activity is defined as the rate of hydrolysis of peptide bonds per milligram of active enzyme.
• Many well known procedures exist for measuring proteolytic activity K. M. Kalisz. "Microbial Proteinases," Advances in Biochemical Engineering/Biotechnology, A. Fiechter ed., 1988).
• the variant enzymes of the present invention may have other modified properties such as K m , ⁇ ,, ⁇ /K m ratio and/or modified substrate specificity and/or modified pH activity profile. These enzymes can be tailored for the particular substrate which is anticipated to be present, for example, in the preparation of peptides or for hydrolytic processes such as laundry uses.
• the objective is to secure a variant protease having altered, preferably improved wash performance as compared to a precursor protease in at least one detergent formulation and or under at least one set of wash conditions.
• wash conditions including varying detergent formulations, wash water volume, wash water temperature and length of wash time that a protease variant might be exposed to.
• detergent formulations used in different areas have different concentrations of their relevant components present in the wash water.
• a European detergent typically has about 4500-5000 ppm of detergent components in the wash water while a Japanese detergent typically has approximately 667 ppm of detergent components in the wash water.
• a detergent typically has about 975 ppm of detergent components present in the wash water.
• a low detergent concentration system includes detergents where less than about 800 ppm of detergent components are present in the wash water.
• Japanese detergents are typically considered low detergent concentration system as they have approximately 667 ppm of detergent components present in the wash water.
• a medium detergent concentration includes detergents where between about 800 ppm and about 2000ppm of detergent components are present in the wash water.
• North American detergents are generally considered to be medium detergent concentration systems as they nave approximately 975 ppm of detergent components present in the wash water. Brazil typically has approximately 1500 ppm of detergent components present in the wash water.
• a high detergent concentration system includes detergents where greater than about 2000 ppm of detergent components are present in the wash water.
• European detergents are generally considered to be high detergent concentration systems as they have approximately 4500-5000 ppm of detergent components in the wash water.
• Latin American detergents are generally high suds phosphate builder detergents and the range of detergents used in Latin America can fall in both the medium and high detergent concentrations as they range from 1500 ppm to 6000 ppm of detergent components in the wash water. As mentioned above, Brazil typically has approximately 1500 ppm of detergent components present in the wash water. However, other high suds phosphate builder detergent geographies, not limited to other Latin American countries, may have high detergent concentration systems up to about 6000 ppm of detergent components present in the wash water.
• concentrations of detergent compositions in typical wash solutions throughout the world varies from less than about 800 ppm of detergent composition ("low detergent concentration geographies”), for example about 667 ppm in Japan, to between about 800 ppm to about 2000 ppm ("medium detergent concentration geographies"), for example about 975 ppm in U.S. and about 1500 ppm in Brazil, to greater than about 2000 ppm ("high detergent concentration geographies”), for example about 4500 ppm to about 5000 ppm in Europe and about 6000 ppm in high suds phosphate builder geographies.
• low detergent concentration geographies for example about 667 ppm in Japan
• intermediate detergent concentration geographies for example about 975 ppm in U.S. and about 1500 ppm in Brazil
• high detergent concentration geographies for example about 4500 ppm to about 5000 ppm in Europe and about 6000 ppm in high suds phosphate builder geographies.
• concentrations of the typical wash solutions are determined empirically For example, in the U S , a typical washing machine holds a volume of about 644 L of wash solution Accordingly, in order to obtain a concentration of about 975 ppm of detergent within the wash solution about 62 79 g of detergent composition must be added to the 64 4 L of wash solution This amount is the typical amount measured into the wash water by the consumer using the measuring cup provided with the detergent
• one aspect of the present invention includes a protease variant that shows improved wash performance in at least one set of wash conditions in another aspect of the invention, it has been determined that substitution of an ammo acid at one or more residue positions corresponding to residue positions selected from the group consisting of 62, 212, 230, 232, 252 and 257 of Bacillus amyloliquefaciens subtilisin are important in improving the wash performance of the enzyme
• substitutions are preferably made in Bacillus lentus (recombinant or native-type) subtilisin, although the substitutions may be made in any Bacillus protease
• protease variants of the invention are useful in formulating various detergent compositions or personal care formulations such as shampoos or lotions
• suitable surfactants useful in compositions comprising the protease mutants of the invention include nonionic, anionic, cationic, or zwittenonic detergents, as disclosed in US 4,404,128 to Barry J Anderson and US 4,261 ,868 to Jin Flora, et al
• a suitable detergent formulation is that described in Example 7 of US Patent 5,204,015 (previously incorporated by reference)
• the art is familiar with the different formulations which can be used as cleaning compositions
• the protease variants of the present invention may be used for any purpose that native or wild-type prote
• variants of the present invention can be used, for example, in bar or liquid soap applications, dishcare formulations, contact lens cleaning solutions or products, peptide hydrolysis, waste treatment, textile applications, as fusion-cleavage enzymes in protein production, etc.
• the variants of the present invention may comprise enhanced performance in a detergent composition (as compared to the precursor).
• enhanced performance in a detergent is defined as increasing cleaning of certain enzyme sensitive stains such as grass or blood, as determined by usual evaluation after a standard wash cycle.
• Proteases of the invention can be formulated into known powdered and liquid detergents having pH between 6.5 and 12.0 at levels of about 0.01 to about 5% (preferably 0.1 % to 0.5%) by weight.
• detergent cleaning compositions can also include other enzymes such as known proteases, amylases, cellulases, upases or endoglycosidases. as well as builders and stabilizers.
• proteases of the invention to conventional cleaning compositions does not create any special use limitation. In other words, any temperature and pH suitable for the detergent is also suitable for the present compositions as long as the pH is within the above range, and the temperature is below the described protease's denaturing temperature.
• proteases of the invention can be used in a cleaning composition without detergents, again either alone or in combination with builders and stabilizers.
• the present invention also relates to cleaning compositions containing the protease variants of the invention.
• the cleaning compositions may additionally contain additives which are commonly used in cleaning compositions. These can be selected from, but not limited to, bleaches, surfactants, builders, enzymes and bleach catalysts. It would be readily apparent to one of ordinary skill in the art what additives are suitable for inclusion into the compositions. The list provided herein is by no means exhaustive and should be only taken as examples of suitable additives. It will also be readily apparent to one of ordinary skill in the art to only use those additives which are compatible with the enzymes and other components in the composition, for example, surfactant.
• the amount of additive present in the cleaning composition is from about 0.01% to about 99.9%. preferably about 1% to about 95%, more preferably about 1% to about 80%.
• the variant proteases of the present invention can be included in animal feed such as part of animal feed additives as described in, for example. US 5,612,055; US 5,314,692; and US 5,147,642.
• compositions for the treatment of a textile that includes variant proteases of the present invention.
• the composition can be used to treat for example silk or wool as described in publications such as RD 216,034: EP 134,267; US 4,533.359; and EP 344,259.
• protease variants were produced and purified using methods well known in the art. All mutations were made in Bacillus lentus GG36 subtilisin. The variants are shown in Table 4.
• Example 1 A large number of the protease variants produced in Example 1 were tested for performance in two types of detergent and wash conditions using a microswatch assay described in "An improved method of assaying for a preferred enzyme and/or preferred detergent composition", U.S. Serial No. 60/068,796.
• Table 5 lists the variant proteases assayed and the results of testing in two different detergents.
• the detergent was 0.67 g/i filtered Ariei Ultra (Procter & Gamble. Cincinnati, OH. USA), in a solution containing 3 grains per gallon mixed Ca2 + /Mg2 + hardness, and 0.3 ppm enzyme was used in each well at 20°C.
• the detergent was 3.38 g/l filtered Ariel Futur (Procter & Gamble,
• Table 6 lists the variant proteases assayed from Example 1 and the results of testing in four different detergents. The same performance tests as in Example 2 were done on the noted variant proteases with the following detergents.
• the detergent was 0.67 g/l filtered Ariel Ultra (Procter & Gamble, Cincinnati, OH,

Landscapes

• Chemical & Material Sciences (AREA)
• Life Sciences & Earth Sciences (AREA)
• Health & Medical Sciences (AREA)
• Organic Chemistry (AREA)
• Engineering & Computer Science (AREA)
• Wood Science & Technology (AREA)
• General Health & Medical Sciences (AREA)
• Chemical Kinetics & Catalysis (AREA)
• Oil, Petroleum & Natural Gas (AREA)
• Zoology (AREA)
• Veterinary Medicine (AREA)
• Bioinformatics & Cheminformatics (AREA)
• Genetics & Genomics (AREA)
• Public Health (AREA)
• Animal Behavior & Ethology (AREA)
• General Engineering & Computer Science (AREA)
• Polymers & Plastics (AREA)
• Biochemistry (AREA)
• Inorganic Chemistry (AREA)
• Food Science & Technology (AREA)
• Microbiology (AREA)
• Epidemiology (AREA)
• Dermatology (AREA)
• Birds (AREA)
• Biomedical Technology (AREA)
• Animal Husbandry (AREA)
• Medicinal Chemistry (AREA)
• Molecular Biology (AREA)
• Oral & Maxillofacial Surgery (AREA)
• Biotechnology (AREA)
• Nutrition Science (AREA)
• Detergent Compositions (AREA)
• Enzymes And Modification Thereof (AREA)
• Micro-Organisms Or Cultivation Processes Thereof (AREA)
• Fodder In General (AREA)
• Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
• Cosmetics (AREA)
• Slot Machines And Peripheral Devices (AREA)
• Exhaust Gas After Treatment (AREA)
• Confectionery (AREA)

Priority Applications (11)

Applications Claiming Priority (6)

Publications (2)

Family

ID=27420734

Family Applications (5)

Family Applications Before (1)

Family Applications After (3)

Country Status (26)

Cited By (23)

Families Citing this family (597)